| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 21.44▼ | 21.46▼ | 21.46▼ | 21.08▲ | 20.65▲ |
| MA10 | 21.46▼ | 21.46▼ | 21.37▲ | 21.03▲ | 19.59▲ |
| MA20 | 21.47▼ | 21.36▲ | 21.15▲ | 20.61▲ | 18.52▲ |
| MA50 | 21.46▼ | 21.07▲ | 21.10▲ | 19.40▲ | 17.45▲ |
| MA100 | 21.40▲ | 21.09▲ | 20.82▲ | 18.32▲ | 15.92▲ |
| MA200 | 21.20▲ | 20.79▲ | 20.08▲ | 17.78▲ | 15.32▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.006▼ | -0.010▼ | 0.033▲ | -0.003▼ | 0.321▲ |
| RSI | 39.960▼ | 64.366▲ | 65.165▲ | 70.398▲ | 75.157▲ |
| STOCH | 13.056▼ | 45.017 | 73.884 | 58.250 | 88.554▲ |
| WILL %R | -88.889▼ | -33.696 | -31.000 | -13.258▲ | -6.652▲ |
| CCI | -120.833▼ | -2.450 | 55.057 | 127.809▲ | 145.252▲ |
|
Thursday, November 12, 2026 04:36 AM
OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda (TSE:4502/NYSE:TAK) announced that ORZEYFUL™ (oveporexton) CIV is now available in the U.S. by prescription for the treatment of narcolepsy ...
|
|
Friday, October 30, 2026 04:14 AM
Takeda Pharmaceutical (NYSE:TAK) reported first-half fiscal 2026 results that management said were in line with expectations as the company invested in new product launches and its late-stage pipeline ...
|
|
Wednesday, October 14, 2026 02:18 AM
Takeda reported Phase 2/3 IgGNITE trial results showing TAK-881 may reduce infusion burden for primary immunodeficiency patients.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 13/11/26 | 21.45 | 21.59 | 21.31 | 21.43 | 3,751,573 |
| 12/11/26 | 21.20 | 21.34 | 21.075 | 21.12 | 3,264,979 |
| 11/11/26 | 20.79 | 20.86 | 20.68 | 20.84 | 1,961,348 |
| 10/11/26 | 20.88 | 20.98 | 20.74 | 20.93 | 2,951,941 |
| 09/11/26 | 21.14 | 21.22 | 20.905 | 21.09 | 2,162,571 |
| 06/11/26 | 20.62 | 21.085 | 20.57 | 21.02 | 2,968,892 |
| 05/11/26 | 21.53 | 21.725 | 21.19 | 21.19 | 4,735,016 |
| 04/11/26 | 20.90 | 21.08 | 20.64 | 21.06 | 2,966,813 |
| 03/11/26 | 20.78 | 20.9076 | 20.705 | 20.75 | 2,575,640 |
| 02/11/26 | 20.88 | 21.17 | 20.78 | 20.87 | 2,650,794 |
|
|
||||
|
|
||||
|
|